# Bioequivalence Study of Bilastine Tablets in Healthy Chinese Subjects

> **NCT06098261** · PHASE1 · UNKNOWN · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 40 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Test (T) Bilastine
- **DRUG:** Reference (R) Bilastine

## Key facts

- **NCT ID:** NCT06098261
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-21
- **Primary completion:** 2023-12-03
- **Final completion:** 2024-09-27
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06098261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06098261, "Bioequivalence Study of Bilastine Tablets in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06098261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*